Clinically Extremely Vulnerable Adults

Last updated 9 May 2022

First Dose Appointments

If you have not not received your invitation for COVID-19 vaccination you can attend a drop-in session.

Second Dose Appointments

If you have not not received your invitation for second dose COVID-19 vaccination ten weeks after your first dose you can attend a drop-in session.

Third Dose Appointments

Welsh Government has adopted recommendations from the JCVI to offer a third dose to certain individuals with severe immunosuppression at the time of their first or second dose. Let us know if you were immunosuppressed at the time of your first or second dose and have not been offered a third primary dose. 

First Booster Programme

Our booster programme is under way. Please check our booster programme page for further information.

Let us know if it is more than three months since your second dose and you have not received your invitation.

Spring Booster Programme

People under 75 are not eligible for a spring booster unless they have severe immunosuppression or are a resident of a care home for older adults. More information is available from our spring booster page.

Further Information

More information about COVID-19 vaccination in Powys is available from our COVID-19 vaccination page.

Please note that national factors such as vaccine approval & availability, and changes to national policy & guidance, will impact on the delivery of our COVID-19 vaccination programme in Powys. This does mean that the information on this page is subject to change. Please keep checking back for the latest information.

About the Clinically Extremely Vulnerable priority group

People aged 16+ who are "clinically extremely vulnerable" are in priority group 4 in the national priority groups for COVID-19 vaccination from the UK's independent Joint Committee on Vaccination and Immunisation.

In line with national guidance this category include:

• Solid organ transplant recipients
• People with specific cancers:
  • People with cancer who are undergoing active chemotherapy or radical radiotherapy for lung cancer
  • People with cancers of the blood or bone marrow such as leukaemia, lymphoma or myeloma who are at any stage of treatment
  • People having immunotherapy or other continuing antibody treatments for cancer
  • People having other targeted cancer treatments which can affect the immune system, such as protein kinase inhibitors or PARP inhibitors
  • People who have had bone marrow or stem cell transplants in the last 6 months, or who are still taking immunosuppression drugs
• People with severe respiratory conditions including all cystic fibrosis, severe asthma and severe Chronic Obstructive Pulmonary Disease (COPD)
• People with severe single organ disease (e.g. Liver, Cardio, Renal, Neurological).
• People with rare diseases and inborn errors of metabolism that significantly increase the risk of infections (such as Severe Combined Immunodeficiency (SCID), homozygous sickle cell).
• People on immunosuppression therapies sufficient to significantly increase risk of infection.
• Adults with Down’s syndrome.
• Pregnant women with significant heart disease, congenital or acquired

More detailed information about how people are identified as “clinically extremely vulnerable” is available from the NHS Wales Informatics Service website.

Guidance published in July 2021 has extended the vaccination programme to include children aged 12-15 with certain conditions that make them clinically extremely vulnerable.